Nasdaq Healthcare & Biotech Listings

Petri Niemisvirta, CEO of Mandatum plc, joins Jill Malandrino on Nasdaq TradeTalks to discuss structural changes and the strategy for excess capital.

In this episode of Breakthrough Economy, SHINE Technologies CEO Greg Piefer chats with Host Jen Rogers about how his company is using fusion technology to tackle today's challenges while also preparing for the future.

In this episode of Breakthrough Economy, MindMed CEO Robert Barrow chats with Host Jen Rogers about how his company, which was the first psychedelic pharmaceutical company to go public, is working to to unlock the full therapeutic potential of psychedelics and other novel therapeutic targets.

In this episode of Breakthrough Economy, Ankur Shah, SVP of Prisma Cloud at Palo Alto Networks, and Wedbush Securities Managing Director Taz Koujalgi join Breakthrough Economy Host Jen Rogers to talk about the rapid growth of the cloud and how investors are looking at the industry as a whole.

In this episode of Breakthrough Economy, Host Jen Rogers and Genenta Co-Founder & CEO Pierluigi Paracchi explore innovative therapies in immuno-oncology and the next advances that could transform the sector and radically improve patient outcomes.

In this episode of Breakthrough Economy, we're exploring Climeworks, a groundbreaking company that is removing and storing carbon. Host Jen Rogers is joined by Co-founder & CEO of Climeworks, Christoph Gebald, to discuss the technology behind the company and the evolution of the industry.

In this episode of Breakthrough Economy, we’re taking a look at how AI is transforming the biotech industry, specifically providing cutting-edge advancements when it comes to oncology. Host Jen Rogers is joined by Lantern Pharma CEO and President Panna Sharma to discuss the evolution, challenges, and future of AI and medicine.

In this episode of Breakthrough Economy, we discuss the behind the scenes technology that powers everything from microwaves to self-driving cars to ChatGPT – semiconductors. Host Jen Rogers is joined by Ziad Asghar, Senior Vice President of Product Management at Qualcomm and Ruben Roy, Applied Technology Analyst at Stifel. The guests explore whether the industry is recession-proof, how AI is going to change the game, advancements we can expect to see in the future and much more.

In this episode of Breakthrough Economy, we are diving into the world of cybersecurity. What are the innovations at the forefront of the field? What softwares are at the front lines of this ongoing battle? Host Jen Rogers is joined by Tom Gillis, SVP and GM of the Security Business Group at Cisco and Dan Ives, MD and Senior Equity Research Analyst at Wedbush Securities.

In this episode of Breakthrough Economy, we discuss the shifts and advances we saw in biotech in 2022, and what's to come in 2023 and beyond for this innovative sector. Host Jen Rogers is joined by George Yancopoulos, co-founder, president and chief scientific officer at Regeneron and managing director and senior biotech analyst at Oppenheimer, Hartaj Singh.

In this episode of Breakthrough Economy, we discuss innovations and challenges in the immuno-oncology space. Host Jen Rogers is joined by Niko Kley, co-founder and CEO of Orionis Biosciences and Dr. Pam Sharma, Professor and Director of Scientific Programs for the James P. Allison Institute at MD Anderson Cancer Center

In this episode of Breakthrough Economy, we explore how developments in the application of mRNA have transformed biotech. Host Jen Rogers is joined by Dr. Bob Langer, Institute Professor at MIT, head of the Langer Lab at MIT, and co-founder of Moderna to discuss what's next for the sector.

In this episode of Breakthrough Economy, host Jen Rogers is joined by Andrew Miller, Ph.D., Founder and COO of Karuna Therapeutics and Paul Matteis, Co-Head of the Biotechnology Research team at Stifel Financial Corp. to explore how biotech innovation is transforming the treatment of neurological and mental health disorders.

In this episode of Breakthrough Economy, we explore how access to capital drives innovation in medicine and beyond. What are the challenges for biotech entrepreneurs? Where is access to capital most critical? What role do incubators play? Host Jen Rogers is joined by Melinda Richter, Global Head of JLABS, Johnson & Johnson Innovation, and Sheila Mikhail, CEO and Co-Founder of Jurata Thin Film to answer these questions and more.

In this episode of Breakthrough Economy, we explore the potential of gene editing in shaping the future of medicine and beyond. How is gene editing transforming therapeutics today and in the future? How can it be applied to other industries? Host Jen Rogers is joined by John Leonard, CEO of Intellia, and Rodolphe Barrangou, Distinguished Professor at NC State and co-founder of Intellia to answer these questions and more.

In this episode of Breakthrough Economy, we explore the groundbreaking potential of cell and gene therapies and look at what this means for patient outcomes now and in the future. Host Jen Rogers is joined by Ali Urman, Genomic Revolution Analyst at ARK Invest, and Sam Kulkarni, CEO at CRISPR Therapeutics.

In this episode of Breakthrough Economy, we explore the transformational shifts in biotech that are accelerating inclusive innovation in research, development and the clinical trial process. This episode features Dr. Michelle McMurry-Heath, CEO of the Bio Innovation Organization (BIO), and Dr. Melanie Ivarsson, Chief Development Officer at Moderna.

In this episode, host Jen Rogers speaks with CRISPR Co-Founder Dr. Jennifer Doudna on the big breakthroughs in CRISPR and its reverberating impact on the future of biotech.